Effects of a long-acting antiarrhythmic agent--QX-572--on therapy resistant ventricular tachyarrhythmias.
作者信息
Rydén L, Hjalmarson A, Wasir H, Werkö L
出版信息
Br Heart J. 1974 Aug;36(8):811-21. doi: 10.1136/hrt.36.8.811.
Abstract
摘要
相似文献
1
Effects of a long-acting antiarrhythmic agent--QX-572--on therapy resistant ventricular tachyarrhythmias.长效抗心律失常药物——QX-572——对难治性室性快速性心律失常的影响。
Br Heart J. 1974 Aug;36(8):811-21. doi: 10.1136/hrt.36.8.811.
2
Lidocaine and the quarternary ammonium compound QX-572 in acute myocardial infarction. A comparative study.
Acta Med Scand. 1978;204(4):311-4. doi: 10.1111/j.0954-6820.1978.tb08445.x.
3
Comparison of methyllidocaine and lidocaine on arrhythmias produced by coronary occlusion in the dog.
Circulation. 1973 Apr;47(4):697-703. doi: 10.1161/01.cir.47.4.697.
4
[Symposium on anti-arrhythmic drugs of the Swedish Society of Cardiology].
Lakartidningen. 1973 Dec 12;70(50):4665-77.
5
Effects of the quaternary ammonium compound OX-572 on ventricular tachyarrhythmias complicating acute myocardial infarction.季铵化合物OX-572对急性心肌梗死并发室性快速心律失常的影响。
Br Heart J. 1975 Apr;37(4):426-37. doi: 10.1136/hrt.37.4.426.
6
Rational use of antiarrhythmic drugs alone and in combination.抗心律失常药物单独及联合使用的合理应用。
Cardiovasc Clin. 1974;6(2):103-17.
7
Lidocaine (Xylocaine) as an anti-arrhythmic agent.利多卡因（赛罗卡因）作为一种抗心律失常药物。
Med Lett Drugs Ther. 1971 Jan 8;13(1):1-2.
8
[Modern therapy of cardiac arrhythmias].[现代心律失常治疗方法]
Schweiz Med Wochenschr. 1973 Feb 24;103(8):272-6.
9
Experimental evaluation of antiarrhythmic drugs in the guinea pig.豚鼠抗心律失常药物的实验评估
Biomedicine. 1973 Jul 20;19(7):308-13.
10
Mechanisms contributing to dysrhythmias induced by ischemia and their therapeutic implications.缺血诱发心律失常的机制及其治疗意义。
Adv Cardiol. 1978(22):110-29. doi: 10.1159/000401022.
引用本文的文献
1
Quaternary Lidocaine Derivatives: Past, Present, and Future.季铵型利多卡因衍生物：过去、现在和未来。
Drug Des Devel Ther. 2021 Jan 14;15:195-207. doi: 10.2147/DDDT.S291229. eCollection 2021.
2
Plasma concentrations and urinary excretion of the antiarrhythmic quaternary ammonium compound QX-572 in man.抗心律失常季铵化合物QX - 572在人体中的血浆浓度及尿排泄情况。
Eur J Clin Pharmacol. 1975 Apr 4;8(3-4):277-82. doi: 10.1007/BF00567128.
本文引用的文献
1
Protein synthesis from aminoacyl-soluble ribonucleic acid.由氨酰可溶性核糖核酸合成蛋白质。
Fed Proc. 1962 Jan-Feb;21:127-33.
2
ANTIARRHYTHMIC AND NEUROMUSCULAR EFFECTS OF QX-572 IN MAN.QX - 572对人体的抗心律失常及神经肌肉作用
Acta Anaesthesiol Scand. 1965;9:73-81. doi: 10.1111/j.1399-6576.1965.tb00496.x.
3
ANTIARRHYTHMIC ACTION OF N, N-BIS (PHENYLCARBAMOYLMETHYL) DIMETHYL AMMONIUM CHLORIDE (QX-572) IN CAT AND DOG.N，N-双（苯基氨基甲酰甲基）二甲基氯化铵（QX-572）对猫和狗的抗心律失常作用
Anesthesiology. 1964 May-Jun;25:291-6. doi: 10.1097/00000542-196405000-00005.
4
Clinical pharmacology of N,N-bis(phenylcarbamolymethyl)dimethylammonium chloride (QX-572), a new antiarrhythmic agent.新型抗心律失常药物N,N-双（苯基氨基甲酰甲基）二甲基氯化铵（QX-572）的临床药理学
J Clin Pharmacol J New Drugs. 1967 Sep-Oct;7(5):278-86. doi: 10.1002/j.1552-4604.1967.tb00065.x.
5
[Experiences of the coronary-care unit at Sahlgrenska hospital].
Lakartidningen. 1971 Aug 4;68(32):3603-10.
6
The use of procaine amide and lidocaine in the treatment of cardiac arrhythmias.普鲁卡因酰胺和利多卡因在心律失常治疗中的应用。
Prog Cardiovasc Dis. 1969 May;11(6):515-34. doi: 10.1016/0033-0620(69)90004-8.
7
The pharmacology and clinical use of lidocaine as an antiarrhythmic drug--1972.
Mod Treat. 1972 Feb;9(1):139-75.
8
Antiarrhythmic agents. I. Mechanisms of action and clinical pharmacology.抗心律失常药物。I. 作用机制与临床药理学。
Drugs. 1973;5(4):261-91. doi: 10.2165/00003495-197305040-00002.
Zotero 插件